Outlook Therapeutics, Inc.
USD1.69
-0.02 (-1.17%)
CEO
Robert Charles Jahr
IPO Date
2016-06-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.72
Prev. Close
$1.71
Day Low
$1.62
Day High
$1.77
52W Low
$0.16
52W High
$3.39
Market Cap
$0.07B
Volume
7.73M
| -1.3 |
| 30 Sept 2023 | FY | 0.0% | 0.0% | 408.5% | -182.6% | -2.46 | 0.66 | -0.9 |
| 30 Sept 2022 | FY | 0.0% | 0.0% | -756.0% | -231.5% | 1.25 | 1.39 | -3.9 |
| 30 Sept 2021 | FY | 0.0% | 0.0% | -1154.0% | -233.1% | 2.58 | 3.19 | -6.2 |
| 30 Sept 2020 | FY | 0.0% | 0.0% | -1247.0% | -178.6% | 3.11 | 1.13 | -1.5 |
| 30 Sept 2019 | FY | -192.2% | -423.8% | 320.6% | -201.5% | -1.39 | 0.67 | -0.8 |
| 30 Sept 2018 | FY | 0.0% | -974.5% | 144.6% | -135.0% | -1.05 | 0.10 | -0.8 |
| 30 Sept 2017 | FY | 0.0% | -1019.1% | 126.4% | -187.4% | -0.60 | 0.14 | -0.8 |
| 30 Sept 2016 | FY | 0.0% | -1788.7% | 1025.0% | -224.8% | -1.68 | 0.28 | -1.1 |
| -1.0 |
| 30 Sept 2025 | Q4 | 1098.5% | 14482.2% | 41.3% | -71.5% | -0.94 | 0.38 | -0.7 |
| 30 Jun 2025 | Q3 | 70.8% | -1338.8% | 54.2% | -90.0% | -0.93 | 0.67 | -0.7 |
| 31 Mar 2025 | Q2 | 0.0% | 0.0% | 142.8% | -243.0% | -1.03 | 0.72 | -0.2 |
| 31 Dec 2024 | Q1 | 0.0% | 0.0% | -34.6% | 102.2% | -0.62 | 0.32 | 0.7 |
| 30 Sept 2024 | Q4 | 50.0% | 3345.2% | -7.8% | 19.7% | -0.41 | 0.64 | 4.4 |
| 30 Jun 2024 | Q3 | 0.0% | 0.0% | -53.1% | 94.3% | -0.39 | 1.07 | 1.0 |
| 31 Mar 2024 | Q2 | 0.0% | 0.0% | 85.1% | -193.6% | -0.33 | 1.07 | -0.3 |
| 31 Dec 2023 | Q1 | 0.0% | 0.0% | 45.9% | -51.5% | -1.50 | 0.44 | -2.3 |